LOCUS LZ129552 18 bp RNA linear PAT 28-OCT-2017 DEFINITION JP 2017513485-A/23689: CRISPR/CAS-RELATED METHODS, COMPOSITIONS AND COMPONENTS FOR CANCER IMMUNOTHERAPY. ACCESSION LZ129552 VERSION LZ129552.1 KEYWORDS JP 2017513485-A/23689. SOURCE synthetic construct ORGANISM synthetic construct other sequences; artificial sequences. REFERENCE 1 (bases 1 to 18) AUTHORS Bumcrot,D.A., Maeder,M.L., Welstead,G.G. and Friedland,A.E. TITLE CRISPR/CAS-RELATED METHODS, COMPOSITIONS AND COMPONENTS FOR CANCER IMMUNOTHERAPY JOURNAL Patent: JP 2017513485-A 23689 01-JUN-2017; EDITAS MEDICINE INC,G Grant WELSTEAD,Ari E FRIEDLAND,Morgan L MAEDER, David A BUMCROT COMMENT OS Artificial Sequence PN JP 2017513485-A/23689 PD 01-JUN-2017 PF 17-APR-2015 JP 2016562958 PR 18-APR-2014 US 61/981636 ,25-MAR-2015 US 62/138246 PA EDITAS MEDICINE INC,G Grant WELSTEAD,Ari E FRIEDLAND,Morgan L PA MAEDER, PA David A BUMCROT PI david a bumcrot,morgan l maeder,g grant welstead,ari e PI friedland PT "CRISPR/CAS-RELATED METHODS, COMPOSITIONS AND COMPONENTS FOR PT CANCER PT IMMUNOTHERAPY" PS N24044 CC Synthetic oligonucleotide: Ptpn6-4618 FH Key Location/Qualifiers FEATURES Location/Qualifiers source 1..18 /mol_type="unassigned RNA" /db_xref="taxon:32630" /organism="synthetic construct" BASE COUNT 1 a 5 c 7 g 5 t ORIGIN 1 gggggtgtcc tcagcttc //